Dyne Therapeutics, Inc. (DYN)
NASDAQ·Healthcare·Biotechnology
$16.93
-0.09%
Mkt Cap $2.92B
Analyst Ratings
Buy
9
Hold
0
Sell
1
Price Target (41 analysts)
$35.20
Range $24.00 – $50.00
Implied Upside
+107.9%
Consensus $35.20 vs current $16.93
NASDAQ·Healthcare·Biotechnology
$16.93
-0.09%
Mkt Cap $2.92B
Buy
9
Hold
0
Sell
1
Price Target (41 analysts)
$35.20
Range $24.00 – $50.00
+107.9%
Consensus $35.20 vs current $16.93